Drugs & medicalClass II

Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L.…

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Read the official notice →
Date
2024-10-23
Country
United States
Brand
Breckenridge Pharmaceutical
Product
Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Distributed by: BPI,…
Classification
Class II
Units
Product was distributed nationwide within the United States
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Breckenridge Pharmaceutical recalls

  1. 2025-04-09
  2. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 1,000 Capsules per bottle, Manufactured by: Towa Pharmaceutical…

    CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.

    FDA · DrugBreckenridge Pharmaceutical, Inc.Nationwide in the USOfficial notice →
  3. 2025-03-19
  4. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L.…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

    FDA · DrugBreckenridge Pharmaceutical, Inc.NationwideOfficial notice →
  5. 2025-01-01
  6. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical…

    CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

    FDA · DrugBreckenridge Pharmaceutical, IncNationwide in the USOfficial notice →
  7. 2024-06-26
  8. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release Capsules, USP, 60mg, 90-count bottle, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles,…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

    FDA · DrugBreckenridge Pharmaceutical, IncNationwide in the USAOfficial notice →
  9. 2024-05-15
  10. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release Capsules, USP, 60 mg, 90-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L.…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

    FDA · DrugBreckenridge Pharmaceutical, IncUS Nationwide.Official notice →
  11. 2023-03-22
  12. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc recalls Alprazolam Tablets, USP, 1 mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0706-01), b) 500-count bottle (NDC…

    CGMP Deviations: Potential risk of Cross Contamination

    FDA · DrugBreckenridge Pharmaceutical, IncUSA nationwide.Official notice →
All 16 Breckenridge Pharmaceutical recalls →

Other drugs & medical recalls in the United States

  1. 2024-10-23
  2. US
    Drugs & medicalClass I

    Bionpharma Inc. recalls Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC #…

    Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

    FDA · DrugBionpharma Inc.Nationwide in the U.S.A.Official notice →
  3. US
  4. US
    Drugs & medicalClass II

    ACCORD HEALTHCARE, INC. recalls Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare…

    Failed Impurities/Degradation Specifications.

    FDA · DrugACCORD HEALTHCARE, INC.Nationwide within the United States and PROfficial notice →
  5. 2024-10-16
  6. US
    Drugs & medicalClass II

    Agfa Healthcare NV recalls Enterprise Imaging XERO Viewer- software application used for reference and diagnostic viewing of multispecialty medical imaging and…

    Software defect, when an image has non-square pixel spacing, the reference/localizer line is incorrectly placed on the scout image in the XERO Viewet, may display the incorrect crosshair/line position on the…

    FDA · DeviceAgfa Healthcare NVUS Nationwide distribution. Foreign: Argentina, Australia, Belgium, Chile,…Official notice →
  7. US
    Drugs & medicalClass II

    Integra LifeSciences Corp. recalls MEDIHONEY Dressing with Active Leptospermum Honey Wound and Burn Dressing W/APPLICATOR, 1.5oz tube (Model Number 31515) and 3.5oz tube…

    There is a potential for pinholes in the applicator pouch film which creates a sterility concern.

    FDA · DeviceIntegra LifeSciences Corp.Worldwide - US Nationwide distribution in the states of MN, IL, UT, FL, NC,…Official notice →
  8. US
    Drugs & medicalClass II

    MEDLINE INDUSTRIES, LP - Northfield recalls Medline Sterile Laparoscopy Pack, DYNJ68187A (REF), containing the component ConMed/Unimax Detachable Endo Pocket

    CONMED Corporation (vendor) initiated a recall for select lot numbers of the Unimax Detachable Endo Pocket. The Detachable Endo Pocket is indicated for use as a receptacle for the collection and extraction of tissues,…

    FDA · DeviceMEDLINE INDUSTRIES, LP - NorthfieldUS Nationwide distribution in the state of CA.Official notice →
See all drugs & medical recalls →